Janssen
Davos Alzheimer's Collaborative, Janssen, Beckman Coulter Partner to Validate Alzheimer's Biomarkers
Samples for the validation will be collected at the Catholic University of Korea and will represent people across all stages of Alzheimer's disease.
Guardant Health Liquid Biopsy CDx Gets Japanese Regulatory Approval for Janssen Lung Cancer Drug
Patients with inoperable or recurrent NSCLC and EGFR exon 20 insertion mutations may be eligible for Janssen Pharmaceutical's amivantamab-vmjw.
FDA Approves FoundationOne Liquid CDx to Select BRCA-Mutated mCRPC Patients for Janssen's Akeega
The FDA expanded the label to include the blood-based sequencing test as well as the tissue-based CDx, which was already approved to select patients for Akeega.
Illumina, Janssen to Collaborate on Molecular Residual Disease Liquid Biopsy Test
The new agreement is part of a long-term strategic collaboration the two firms signed in 2022 to develop precision medicines.
Genetic Contributors to Plasma Protein Levels Unearthed in Multiple Studies
Researchers used Pharma Proteomics Project plasma protein profiles for UK Biobank participants to identify genetic associations with protein levels, providing disease clues.